Pharming Group (Netherlands) Investor Sentiment

PHARM Stock  EUR 0.81  0.02  2.53%   
About 55% of Pharming Group's investors are presently thinking to get in. The analysis of current outlook of investing in Pharming Group NV suggests that some traders are interested regarding Pharming Group's prospects. The current market sentiment, together with Pharming Group's historical and current headlines, can help investors time the market. In addition, many technical investors use Pharming Group NV stock news signals to limit their universe of possible portfolio assets.
  
few days ago at news.google.com         
Pharming Group Reports Strong Revenue Growth for 2024 - TipRanks
Google News at Macroaxis
few days ago at news.google.com         
Pharming Group Smashes Revenue Targets RUCONEST and Joenja Drive Record-Breaking 2024 - StockTitan
Google News at Macroaxis
over a week ago at news.google.com         
Pharming Group Expected to Announce Earnings on Thursday - Defense World
Google News at Macroaxis
over three weeks ago at news.google.com         
Technical Data - Stock Traders Daily
Google News at Macroaxis
over a month ago at news.google.com         
Pharming Group Stock Passes Below 50-Day Moving Average - Whats Next - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Pharming Group to participate in February investor conference - Yahoo Finance UK
Google News at Macroaxis
over a month ago at news.google.com         
Pharming Group Trading 5.7 percent Higher - Heres Why - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
When the Price of Talks, People Listen - Stock Traders Daily
Google News at Macroaxis
over a month ago at news.google.com         
Pharming Group Trading Up 5.4 percent - Heres Why - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Pharming Group Shares Gap Up - Whats Next - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Pharming Group Announces EGM for Leadership Transition - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Pharming Group Shares Gap Down - Heres Why - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
Short Interest in Pharming Group Grows By 149.0 percent - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
Pharming Group Stock Price Down 3.4 percent - Whats Next - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
Pharming Group N.V. Held Back By Insufficient Growth Even After Shares Climb 26 percent - Simply Wal...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pharming Group that are available to investors today. That information is available publicly through Pharming media outlets and privately through word of mouth or via Pharming internal channels. However, regardless of the origin, that massive amount of Pharming data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pharming Group news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pharming Group relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pharming Group's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pharming Group alpha.

Pharming Group Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.152025FebMar -5051015
JavaScript chart by amCharts 3.21.15Pharming Group NV Pharming Group NV Dividend Benchmark Dow Jones Industrial
       Timeline  

Complementary Tools for Pharming Stock analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal